SD Biotechnologies Balance Sheet Health
Financial Health criteria checks 1/6
SD Biotechnologies has a total shareholder equity of ₩19.1B and total debt of ₩59.1B, which brings its debt-to-equity ratio to 308.7%. Its total assets and total liabilities are ₩100.0B and ₩80.8B respectively.
Key information
308.7%
Debt to equity ratio
₩59.06b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩4.83b |
| Equity | ₩19.13b |
| Total liabilities | ₩80.84b |
| Total assets | ₩99.97b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A217480's short term assets (₩34.9B) do not cover its short term liabilities (₩78.6B).
Long Term Liabilities: A217480's short term assets (₩34.9B) exceed its long term liabilities (₩2.3B).
Debt to Equity History and Analysis
Debt Level: A217480's net debt to equity ratio (283.5%) is considered high.
Reducing Debt: A217480's debt to equity ratio has increased from 8.3% to 308.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A217480 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A217480 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.8% each year